Katherine Van Loon, MD, MPH
Professor
Medicine
School of Medicine

Dr. Katherine Van Loon is a Professor of Medicine with clinical expertise in the management of gastrointestinal cancers. She has a particular interest in colorectal and anal cancers.

Show full bio (180 words) Hide full bio

As Director of the Global Cancer Program at the UCSF Helen Diller Family Comprehensive Cancer Center, Dr. Van Loon oversees UCSF’s portfolio of research and capacity-building projects in low and middle-income countries as well as educational programs for training in global oncology. Her research interest focuses on the epidemiology of gastrointestinal cancers both in the United States and globally, with the aim to improve clinical outcomes and reduce disparities in vulnerable populations.

Dr. Van Loon earned her master's degree in public health from the Yale School of Public Health before attending the Medical College of Georgia. She completed a residency in internal medicine at Beth Israel Deaconess Medical Center, a teaching hospital of Harvard Medical School. She came to UCSF for a fellowship in oncology in 2009 and subsequently joined the faculty at UCSF in 2012.

Dr. Van Loon is a member of the American Society of Clinical Oncology (ASCO), the African Organization for Research and Training in Cancer (AORTIC), and the African Esophageal Cancer Consortium (AfrECC). She has been the recipient of numerous awards in mentorship.

Awards

Show all (9) Hide

• #SheforShe Award Nomination, Women In Medicine Summit, 2023
• Faculty Learning and Development Award, UCSF Chancellor's Fund, 2022
• U.S. Cohort Member, WomenLift Health Leadership Journey, 2021
• Hematology/Oncology Marc A. Shuman Mentoring Award, UCSF Department of Medicine, 2018
• Pathways Mentorship Award, UCSF School of Medicine, 2017
• The Ernest H. Rosenbaum, MD Commitment to Patient Care Award, UCSF Helen Diller Family Comprehensive Cancer Center, 2016
• Scholar, AHRQ K12 PARTNERS Program, 2013-2015
• Clinical Investigator Scholarship, North American NeuroEndocrine Tumor Society (NANETS), 2013
• Young Investigator Award, ASCO Conquer Cancer Foundation, 2012

Education & Training

Show all (5) Hide

• Fellow Medical Oncology UCSF 2011
• Resident Internal Medicine Beth Israel Deaconess, Harvard Medical School 2009
• M.D. Medical College of Georgia 2006
• M.P.H. Yale University School of Epidemiology and Public Health 2002
• B.S. Duke University 2000

Websites

Show all (2) Hide

• HDFCCC Global Cancer Program (cancer.ucsf.edu)
• Gastrointestinal Oncology Survivorship Clinic (cancer.ucsf.edu)

Grants and Projects

Show all (1) Hide

• Building a Cancer Research Training Program in Tanzania, NIH, 2020-2025

Publications (117)

Top publication keywords:
Esophageal NeoplasmsColorectal NeoplasmsPancreatic NeoplasmsSexual Dysfunction, PhysiologicalPregnancy Complications, NeoplasticCancer SurvivorsAcademic SuccessNeoplasmsNeuroendocrine TumorsCarcinoma, Squamous CellRectal NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsSupreme Court DecisionsMedical OncologyTanzania

• A roadmap to establishing global oncology as a priority initiative within a National Cancer Institute-designated cancer center.
  Journal of the National Cancer Institute 2024 Van Loon K, Breithaupt L, Ng D, DeBoer RJ, Buckle GC, Bialous S, Hiatt RA, Volberding P, Hermiston ML, Ashworth A
• A Genomic Analysis of Esophageal Squamous Cell Carcinoma in Eastern Africa.
  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2023 Van Loon K, Mmbaga EJ, Mushi BP, Selekwa M, Mwanga A, Akoko LO, Mwaiselage J, Mosha I, Ng DL, Wu W, Silverstein J, Mulima G, Kaimila B, Gopal S, Snell JM, Benz SC, Vaske C, Sanborn Z, Sedgewick AJ, …
• The Implications of the Supreme Court Decision to Overturn Roe v Wade for Women With Pregnancy-Associated Cancers.
  JAMA oncology 2022 Silverstein J, Van Loon K
• Strategically striving to be more inclusive: A recommendation for gender-neutral human-papillomavirus vaccine policies.
  Human vaccines & immunotherapeutics 2025 Xu MJ, Okerosi S, Nkya A, Van Loon K
• Efforts to strengthen anatomic pathology diagnostic services for cancer in sub-Saharan Africa: a scoping review protocol.
  BMJ open 2025 Ng DL, Edelweiss M, Kimambo AH, Vuhahula E, Mushi BP, Adegoke O, Goldberg J, Ibrahim PM, Illonga Z, Jackman J, Jamisse L, Van Loon K, Mmbaga EJ

Show all (112 more) Hide

• FNAB samples with the STRAT4 assay for breast cancer diagnosis - Authors' reply.
  The Lancet. Oncology 2025 Ng DL, Van Loon K, Weidler J, Bates M, Mmbaga EJ, Vuhahula E
• Treatment initiation and completion among head and neck squamous cell carcinoma patients in Tanzania.
  BMC research notes 2024 Xu MJ, Haddadi S, Mushi BP, Zhang L, Sama G, Nyagabona SK, Ng D, Muya S, Malango AE, Richard E, Ha P, Yom SS, Massawe W, Mmbaga EJ, Van Loon K, Nkya A
• Colorectal cancer survival in Mexico: Leveraging a national health insurance database.
  Cancer epidemiology 2024 Lozano-Esparza S, Sánchez-Blas HR, Huitzil-Meléndez FD, Meneses-Medina MI, Van Loon K, Potter MB, Mohar A, Lajous M
• Xpert Breast Cancer STRAT4 Assay using fine-needle aspiration biopsy samples in a resource-constrained setting: a prospective diagnostic accuracy study.
  The Lancet. Oncology 2024 Ng DL, Vuhahula E, Kimambo AH, Ndayisaba MC, Philipo GS, Mushi BP, Ho KE, Paciorek A, Illonga Z, Zhang L, Vohra P, Weidler J, Bates M, Mmbaga EJ, Van Loon K
• Using context-specific evidence to inform resource-stratified cancer guidelines: A call for a new approach.
  Cancer 2024 Buckle GC, DeBoer R, Xu MJ, Mrema A, Rubagumya F, Velloza J, Falade AS, Van Loon K
• Synchronous or metachronous breast and colorectal cancers in younger-than-average-age patients: a case series.
  The oncologist 2024 Silverstein J, Wright F, Stanfield D, Chien AJ, Wong JM, Park JW, Blanco A, Van Loon K, Atreya CE
• Association between gastrointestinal symptoms and specialty care utilization among colon cancer survivors: a cohort study.
  International journal of colorectal disease 2024 Edwards AL, Trang K, Tolstykh IV, Van Blarigan EL, Van Loon K, Laffan A, Stanfield D, Steiding P, Neuhaus J, Atreya CE, Piawah S, Venook AP, Varma MG
• Emerging Therapies for the Management of Human Epidermal Growth Factor Receptor 2-/ERBB2-Altered Advanced Biliary Tract Cancers.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2024 Zeme EL, Van Loon K, Kelley RK, Gordan JD
• Clinical Trials in Gastroesophageal Cancers: An Analysis of the Global Landscape of Interventional Trials From ClinicalTrials.gov.
  JCO global oncology 2024 Falade AS, Adeoye O, Van Loon K, Buckle GC
• Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2024 Parikh AR, Chee BH, Tsai J, Rich TA, Price KS, Patel SA, Zhang L, Ibrahim F, Esquivel M, Van Seventer EE, Jarnagin JX, Raymond VM, Corvera CU, Hirose K, Nakakura EK, Corcoran RB, Van Loon K, Atreya CE
• Evaluation of Culture Conducive to Academic Success by Gender at a Comprehensive Cancer Center.
  The oncologist 2024 Keenan BP, Sibley A, Zhang L, Westring AF, Velazquez AI, Bank EM, Bergsland EK, Boreta L, Conroy P, Daras M, Hermiston M, Hsu G, Paris PL, Piawah S, Sinha S, Sosa JA, Tsang M, Venook AP, Wong M, Yom …
• Ethical dilemmas in prioritizing patients for scarce radiotherapy resources.
  BMC medical ethics 2024 DeBoer RJ, Ho A, Mutoniwase E, Nguyen C, Umutesi G, Bigirimana JB, Nsabimana N, Van Loon K, Shulman LN, Triedman SA, Cubaka VK, Shyirambere C
• COVID-19 pandemic stress and cancer symptom burden.
  BMJ supportive & palliative care 2024 Ballesteros O, Mark S, Block A, Mackin L, Paul S, Cooper B, Abbott M, Chang S, Hammer MJ, Levine J, Pozzar R, Snowberg K, Tsai K, Van Blarigan E, Van Loon K, Miaskowski CA
• Rapid Onsite Evaluation for Specimen Adequacy and Triage of Breast Masses in a Low-Resource Setting.
  Archives of pathology & laboratory medicine 2024 Kimambo AH, Vuhahula EA, Philipo GS, Mushi BP, Mmbaga EJ, Van Loon K, Ng DL
• Expert Commentary on Colon Cancer and the Pregnant Patient.
  Diseases of the colon and rectum 2023 Van Loon K
• Tracheostomy care quality improvement in low- and middle-income countries: A scoping review.
  PLOS global public health 2023 Selekwa M, Maina I, Yeh T, Nkya A, Ncogoza I, Nuss RC, Mushi BP, Haddadi S, Van Loon K, Mbaga E, Massawe W, Roberson DW, Dharsee N, Musimu B, Xu MJ
• Risk of Death Due to Pregnancy-Associated Cancers-More Questions Than Answers.
  JAMA oncology 2023 Silverstein J, Van Loon K
• Feasibility and Clinical Acceptability of Automation-Assisted 3D Conformal Radiotherapy Planning for Patients With Cervical Cancer in a Resource-Constrained Setting.
  JCO global oncology 2023 Muya S, Ndumbalo J, Kutika Nyagabona S, Yusuf S, Rhee DJ, Mushi BP, Li B, Zhang L, Grover S, Feng M, Hsu IC, Mmbaga E, Van Loon K, Court L, Xu M
• Risk Factors for a Higher Symptom Burden in Patients With Cancer During the COVID-19 Pandemic.
  Oncology nursing forum 2023 Hun Kwak J, Mackin LA, Block A, Paul SM, Cooper BA, Abbott M, Chang SM, Hammer MJ, Kober KM, Levine JD, Pozzar R, Rhoads KF, Snowberg KE, Tsai KK, Van Blarigan EL, Van Loon K, Miaskowski C
• Variety of Fruit and Vegetables and Alcohol Intake are Associated with Gut Microbial Species and Gene Abundance in Colorectal Cancer Survivors.
  The American journal of clinical nutrition 2023 Kyaw TS, Upadhyay V, Tolstykh I, Van Loon K, Laffan A, Stanfield D, Gempis D, Kenfield SA, Chan JM, Piawah S, Atreya CE, Ng K, Venook A, Kidder W, Turnbaugh PJ, Van Blarigan EL
• Barriers and confidence among colorectal and prostate cancer survivors participating in two behavioral intervention studies.
  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2023 Liu VN, Zuniga KB, Paciorek A, Zhang L, Chan JM, Carroll PR, Van Loon K, Laffan A, Venook A, Van Blarigan EL, Kenfield SA
• Sexual function remains persistently low in women after treatment for colorectal cancer and anal squamous cell carcinoma.
  The journal of sexual medicine 2023 Savoie MB, Paciorek A, Van Loon K, Anwar M, Atreya CE, Johnson PC, Kenfield SA, Laffan A, Levin AO, Smith JF, Stanfield D, Venook A, Zhang L, Van Blarigan EL, Rowen T
• Quality of life among colorectal cancer survivors participating in a pilot randomized controlled trial of a web-based dietary intervention with text messages.
  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2023 Wang L, Langlais C, Kenfield SA, Van Loon K, Laffan A, Atreya CE, Chan JM, Zhang L, Allen IE, Miaskowski C, Fukuoka Y, Meyerhardt JA, Venook AP, Van Blarigan EL
• The radiologist's role in a multidisciplinary approach to cancer in pregnancy.
  Abdominal radiology (New York) 2023 Harwin J, Jha P, Post A, Silverstein J, Van Loon K, Poder L
• Multi-Disciplinary Management in Rectal Cancer Survivorship: A Clinical Practice Review.
  Journal of gastrointestinal cancer 2023 Chan H, Savoie MB, Munir A, Moslehi J, Anwar M, Laffan A, Rowen T, Salmon R, Varma M, Van Loon K
• Human Papillomavirus-Associated Head and Neck Malignancies in Sub-Saharan Africa: A Systematic Review.
  JCO global oncology 2023 Okerosi S, Mokoh LW, Rubagumya F, Niyibizi BA, Nkya A, Van Loon K, Buckle G, Bent S, Ha P, Fagan JJ, Ng D, Aswani J, Xu MJ
• Phase I prospective trial of TAS-102 (trifluridine and tipiracil) and radioembolization with 90Y resin microspheres for chemo-refractory colorectal liver metastases.
  BMC cancer 2022 Fidelman N, Atreya CE, Griffith M, Milloy MA, Carnevale J, Cinar P, Venook AP, Van Loon K
• Evaluation of Human Epidermal Growth Factor Receptor 2 Expression in Gastric and Gastroesophageal Cancers in Tanzania.
  Archives of pathology & laboratory medicine 2022 Ngaiza A, Vuhahula E, Yahaya J, Ndayisaba MC, Kawishe GJ, Grenert JP, Zhang L, Van Loon K, Ng DL
• Association between adherence to the American Cancer Society Nutrition and Physical Activity Guidelines and stool frequency among colon cancer survivors: a cohort study.
  Journal of cancer survivorship : research and practice 2022 Greenberg AL, Tolstykh IV, Van Loon K, Laffan A, Stanfield D, Steiding P, Kenfield SA, Chan JM, Atreya CE, Piawah S, Kidder W, Venook AP, Van Blarigan EL, Varma MG
• Delayed diagnostic evaluation of symptomatic breast cancer in sub-Saharan Africa: A qualitative study of Tanzanian women.
  PloS one 2022 Sakafu LL, Philipo GS, Malichewe CV, Fundikira LS, Lwakatare FA, Van Loon K, Mushi BP, DeBoer RJ, Bialous SA, Lee AY
• An international report on bacterial communities in esophageal squamous cell carcinoma.
  International journal of cancer 2022 Nomburg J, Bullman S, Nasrollahzadeh D, Collisson EA, Abedi-Ardekani B, Akoko LO, Atkins JR, Buckle GC, Gopal S, Hu N, Kaimila B, Khoshnia M, Malekzadeh R, Menya D, Mmbaga BT, Moody S, Mulima G, Mushi…
• Invited Commentary: Role of the Radiologist in Pregnancy-associated Cancer.
  Radiographics : a review publication of the Radiological Society of North America, Inc 2022 Silverstein J, Van Loon K
• Expanding oesophageal cancer research and care in eastern Africa.
  Nature reviews. Cancer 2022 African Esophageal Cancer Consortium
• Survival in Young-Onset Metastatic Colorectal Cancer: Findings From Cancer and Leukemia Group B (Alliance)/SWOG 80405.
  Journal of the National Cancer Institute 2022 Lipsyc-Sharf M, Zhang S, Ou FS, Ma C, McCleary NJ, Niedzwiecki D, Chang IW, Lenz HJ, Blanke CD, Piawah S, Van Loon K, Bainter TM, Venook AP, Mayer RJ, Fuchs CS, Innocenti F, Nixon AB, Goldberg R, O'…
• Capacidad de colonoscopías diagnósticas en la Ciudad de México
  Salud Publica Mex 2022 Manzano-Robleda MDC, Espinosa-Tamez P, Potter MB, Hernández-Guerrero A, Van Loon K, Unger-Saldaña K
• Developing a collaborative international partnership for cancer control in Mexico
  Salud Publica Mex 2022 Van Loon K, Mohar A, Unger-Saldaña K, Potter MB, Sweet-Cordero EA, Breithaupt L, Espinosa-Tamez P, Sepúlveda-Amor J, Lajous M.
• Quality of life of colorectal cancer survivors participating in a pilot randomized controlled trial of physical activity trackers and daily text messages.
  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2022 Chan H, Van Loon K, Kenfield SA, Chan JM, Mitchell E, Zhang L, Paciorek A, Joseph G, Laffan A, Atreya C, Fukuoka Y, Miaskowski C, Meyerhardt JA, Venook AP, Van Blarigan EL
• Risk Factors Associated With Early-Onset Esophageal Cancer in Tanzania.
  JCO global oncology 2022 Buckle GC, Mmbaga EJ, Paciorek A, Akoko L, Deardorff K, Mgisha W, Mushi BP, Mwaiselage J, Hiatt RA, Zhang L, Van Loon K
• Treatment outcomes of esophageal cancer in Eastern Africa: protocol of a multi-center, prospective, observational, open cohort study.
  BMC cancer 2022 Buckle GC, Mrema A, Mwachiro M, Ringo Y, Selekwa M, Mulima G, Some FF, Mmbaga BT, Mody GN, Zhang L, Paciorek A, Akoko L, Ayuo P, Burgert S, Bukusi E, Charles A, Chepkemoi W, Chesumbai G, Kaimila B, …
• Feasibility and Acceptability of a Physical Activity Tracker and Text Messages to Promote Physical Activity During Chemotherapy for Colorectal Cancer: Pilot Randomized Controlled Trial (Smart Pace II).
  JMIR cancer 2022 Van Blarigan EL, Dhruva A, Atreya CE, Kenfield SA, Chan JM, Milloy A, Kim I, Steiding P, Laffan A, Zhang L, Piawah S, Fukuoka Y, Miaskowski C, Hecht FM, Kim MO, Venook AP, Van Loon K
• Characteristics and Growth Rate of Lung Metastases in Patients With Primary Gastrointestinal Malignancies and Lung-dominant Metastatic Disease: A Retrospective Cohort Analysis.
  American journal of clinical oncology 2022 Burns S, Vella M, Paciorek A, Zhang L, Atreya CE, Feng M, Kelley RK, Tempero MA, Van Loon K, Ko AH
• Being Present 2.0: Online Mindfulness-Based Program for Metastatic Gastrointestinal Cancer Patients and Caregivers.
  Global advances in health and medicine 2021 Dragomanovich HM, Dhruva A, Ekman E, Schoenbeck KL, Kubo A, Van Blarigan EL, Borno HT, Esquivel M, Chee B, Campanella M, Philip EJ, Rettger JP, Rosenthal B, Van Loon K, Venook AP, Boscardin C, Moran P…
• National and state-level colorectal cancer mortality trends in Mexico, 1998-2018.
  Salud publica de Mexico 2021 Espinosa-Tamez P, Suazo-Zepeda E, Sánchez-Blas H, Meneses-Medina M, Huitzil-Meléndez FD, Van Loon K, Potter M, Lajous M
• Evaluating Estrogen Receptor Immunohistochemistry on Cell Blocks From Breast Cancer Patients in a Low-Resource Setting.
  Archives of pathology & laboratory medicine 2021 Kimambo AH, Vuhahula EA, Mwakigonja AR, Ljung BM, Zhang L, Van Loon K, Ng DL
• Views from Multidisciplinary Oncology Clinicians on Strengthening Cancer Care Delivery Systems in Tanzania.
  The oncologist 2021 Nyagabona SK, Luhar R, Ndumbalo J, Mvungi N, Ngoma M, Meena S, Siu S, Said M, Mwaiselage J, Tarimo E, Buckle G, Selekwa M, Mushi B, Mmbaga EJ, Van Loon K, DeBoer RJ
• Molecular and Radiological Features of Microsatellite Stable Colorectal Cancer Cases With Dramatic Responses to Immunotherapy.
  Anticancer research 2021 Keenan BP, VAN Loon K, Khilnani AD, Fidelman N, Behr SC, Atreya CE, Oh DY
• Pragmatic Solutions to Counteract the Regressive Effects of the COVID-19 Pandemic for Women in Academic Oncology.
  JAMA oncology 2021 Keenan B, Jagsi R, Van Loon K
• Moral Distress and Resilience Associated with Cancer Care Priority Setting in a Resource-Limited Context.
  The oncologist 2021 DeBoer RJ, Mutoniwase E, Nguyen C, Ho A, Umutesi G, Nkusi E, Sebahungu F, Van Loon K, Shulman LN, Shyirambere C
• A mixed methods needs assessment and gap analysis for establishment of a cancer research training program in East Africa.
  Journal of global health reports 2021 Nyagabona SK, Mushi BP, Selekwa M, Philipo GS, Haddadi S, Kadhim EF, Breithaupt L, Maongezi S, Mwaiselage J, Balandya E, Leyna GH, Van Loon K, Mmbaga EJ
• Loneliness and symptom burden in oncology patients during the COVID-19 pandemic.
  Cancer 2021 Miaskowski C, Paul SM, Snowberg K, Abbott M, Borno HT, Chang SM, Chen LM, Cohen B, Cooper BA, Hammer MJ, Kenfield SA, Kober KM, Laffan A, Levine JD, Pozzar R, Rhoads K, Tsai KK, Van Blarigan EL, Van …
• Recurrence Patterns After Surgical Resection of Gastroenteropancreatic Neuroendocrine Tumors: Analysis From the National Comprehensive Cancer Network Oncology Outcomes Database.
  Pancreas 2021 Chan H, Zhang L, Choti MA, Kulke M, Yao JC, Nakakura EK, Bloomston M, Benson AB, Shah MH, Strosberg JR, Bergsland EK, Van Loon K
• Use of advanced PET-volume metrics predicts risk of local recurrence and overall survival in anal cancer.
  PloS one 2021 Susko MS, Lazar AA, Wang CJ, Van Loon K, Feng M, Hope TA, Behr S, Anwar M
• Feasibility of Fine-Needle Aspiration Biopsy and Rapid On-Site Evaluation for Immediate Triage in Breast Cancer Screening in Tanzania.
  JCO global oncology 2021 Philipo GS, Vuhahula E, Kimambo A, Mmbaga EJ, Van Loon K, Ng DL
• Improving Access to Self-Expanding Metal Stents for Patients With Esophageal Cancer in Eastern Africa: A Stepwise Implementation Strategy.
  JCO global oncology 2021 Mushi BP, Mwachiro MM, Buckle G, Kaimila BN, Mulima G, Kayamba V, Kelly P, Akoko L, Mmbaga EJ, Selekwa M, Ringo Y, Pritchett N, White RE, Topazian MD, Fleischer DE, Dawsey SM, Van Loon K
• Multisector Collaborations and Global Oncology: The Only Way Forward.
  JCO global oncology 2021 Blanchard C, Lubuzo B, Asirwa FC, Dlamini X, Msadabwe-Chikuni SC, Mwachiro M, Shyirambere C, Ruhangaza D, Milner DA, Van Loon K, DeBoer R, Mtshali P, Dugan U, Baker E, Shulman LN
• A Case-Control Study to Evaluate Environmental and Lifestyle Risk Factors for Esophageal Cancer in Tanzania.
  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2020 Mmbaga EJ, Mushi BP, Deardorff K, Mgisha W, Akoko LO, Paciorek A, Hiatt RA, Buckle GC, Mwaiselage J, Zhang L, Van Loon K
• Optimal management of esophageal cancer in Africa: A systemic review of treatment strategies.
  International journal of cancer 2020 Buckle GC, Mahapatra R, Mwachiro M, Akoko L, Mmbaga EJ, White RE, Bent S, Van Loon K
• Association of Diet Quality With Survival Among People With Metastatic Colorectal Cancer in the Cancer and Leukemia B and Southwest Oncology Group 80405 Trial.
  JAMA network open 2020 Van Blarigan EL, Zhang S, Ou FS, Venlo A, Ng K, Atreya C, Van Loon K, Niedzwiecki D, Giovannucci E, Wolfe EG, Lenz HJ, Innocenti F, O'Neil BH, Shaw JE, Polite BN, Hochster HS, Atkins JN, Goldberg RM, …
• Stress and Symptom Burden in Oncology Patients During the COVID-19 Pandemic.
  Journal of pain and symptom management 2020 Miaskowski C, Paul SM, Snowberg K, Abbott M, Borno H, Chang S, Chen LM, Cohen B, Hammer MJ, Kenfield SA, Kober KM, Levine JD, Pozzar R, Rhoads KF, Van Blarigan EL, Van Loon K
• Applying Lessons Learned From Low-Resource Settings to Prioritize Cancer Care in a Pandemic.
  JAMA oncology 2020 DeBoer RJ, Fadelu TA, Shulman LN, Van Loon K
• Multidisciplinary Management of Cancer During Pregnancy.
  JCO oncology practice 2020 Silverstein J, Post AL, Chien AJ, Olin R, Tsai KK, Ngo Z, Van Loon K
• Oncology patients' perceptions of and experiences with COVID-19.
  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2020 Miaskowski C, Paul SM, Snowberg K, Abbott M, Borno H, Chang S, Chen LM, Cohen B, Cooper BA, Hammer MJ, Kenfield SA, Laffan A, Levine JD, Pozzar R, Tsai KK, Van Blarigan EL, Van Loon K
• The Effect of Disclosing Life Expectancy Information on Patients' Prognostic Understanding: Secondary Outcomes From a Multicenter Randomized Trial of a Palliative Chemotherapy Educational Intervention.
  Journal of pain and symptom management 2020 Enzinger AC, Uno H, McCleary N, Frank E, Sanoff H, Van Loon K, Matin K, Bullock A, Cronin C, Bagley J, Schrag D
• Effectiveness of a Multimedia Educational Intervention to Improve Understanding of the Risks and Benefits of Palliative Chemotherapy in Patients With Advanced Cancer: A Randomized Clinical Trial.
  JAMA oncology 2020 Enzinger AC, Uno H, McCleary N, Frank E, Sanoff H, Van Loon K, Matin K, Bullock A, Cronin C, Cibotti H, Bagley J, Schrag D
• Faecal immunochemical test-based colorectal cancer screening in Mexico: an initial experience.
  Family practice 2020 Remes-Troche JM, Hinojosa-Garza G, Espinosa-Tamez P, Meixueiro-Daza A, Grube-Pagola P, Van Loon K, Potter MB, Lajous M
• Fecal Immunologic Test Results and Diagnostic Colonoscopy in a Mexican Population at Average Risk for Colorectal Cancer.
  Cancer prevention research (Philadelphia, Pa.) 2020 Manzano-Robleda MDC, Espinosa-Tamez P, Potter MB, Lajous M, Van Loon K, Zhang L, Jimenez-Peña A, Sánchez Del Monte J, Mohar A, Hernández-Guerrero A
• Barriers and facilitators for colorectal cancer screening in a low-income urban community in Mexico City.
  Implementation science communications 2020 Unger-Saldaña K, Saldaña-Tellez M, Potter MB, Van Loon K, Allen-Leigh B, Lajous M
• Factors Impacting Differential Outcomes in the Definitive Radiation Treatment of Anal Cancer Between HIV-Positive and HIV-Negative Patients.
  The oncologist 2020 Susko M, Wang CJ, Lazar AA, Kim S, Laffan A, Feng M, Ko A, Venook AP, Atreya CE, Van Loon K, Anwar M
• Development of a theory-driven implementation strategy for cancer management guidelines in sub-Saharan Africa.
  Implementation science communications 2020 DeBoer RJ, Ndumbalo J, Meena S, Ngoma MT, Mvungi N, Siu S, Selekwa M, Nyagabona SK, Luhar R, Buckle G, Lin TK, Breithaupt L, Kennell-Heiling S, Mushi B, Philipo GS, Mmbaga EJ, Mwaiselage J, Van Loon K
• Clinicopathologic Characteristics and Impact of Oophorectomy for Ovarian Metastases from Colorectal Cancer.
  The oncologist 2020 Ursem C, Zhou M, Paciorek A, Atreya CE, Ko AH, Venook A, Zhang L, Van Loon K
• Postoperative Exacerbation of Oxaliplatin-induced Neurotoxicity in Gastrointestinal Cancers: A Case Series.
  Anticancer research 2020 Gonzalez A, Walker EJ, Van Loon K, Cinar P, Atreya CE
• Feasibility and Acceptability of a Web-Based Dietary Intervention with Text Messages for Colorectal Cancer: A Randomized Pilot Trial.
  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2020 Van Blarigan EL, Kenfield SA, Chan JM, Van Loon K, Paciorek A, Zhang L, Chan H, Savoie MB, Bocobo AG, Liu VN, Wong LX, Laffan A, Atreya CE, Miaskowski C, Fukuoka Y, Meyerhardt JA, Venook AP
• Vitamin D Levels in Patients with Colorectal Cancer Before and After Treatment Initiation.
  Journal of gastrointestinal cancer 2019 Savoie MB, Paciorek A, Zhang L, Van Blarigan EL, Sommovilla N, Abrams D, Atreya CE, Bergsland EK, Chern H, Kelley RK, Ko A, Laffan A, Sarin A, Varma MG, Venook AP, Van Loon K
• A multi-disciplinary model of survivorship care following definitive chemoradiation for anal cancer.
  BMC cancer 2019 Savoie MB, Laffan A, Brickman C, Daniels B, Levin A, Rowen T, Smith J, Van Blarigan EL, Hope TA, Berry-Lawhorn JM, Anwar M, Van Loon K
• Patients' information needs and attitudes about post-treatment surveillance for colorectal cancer in the United States: a multi-perspective, mixed methods study.
  BMJ open 2019 Lowenstein LM, Volk RJ, Cuddy A, Hempstead AP, You YN, Van Loon K, Millas S, Meyerhardt JA, Gavin P, Chang GJ
• Correlation of DOTATOC Uptake and Pathologic Grade in Neuroendocrine Tumors.
  Pancreas 2019 Chan H, Moseley C, Zhang L, Bergsland EK, Pampaloni MH, Van Loon K, Hope TA
• Hormone receptor expression of colorectal cancer diagnosed during the peri-partum period.
  Endocrine connections 2019 Silverstein J, Kidder W, Fisher S, Hope TA, Maisel S, Ng D, Van Ziffle J, Atreya CE, Van Loon K
• Vitamin D Levels in Patients with Colorectal Cancer and Matched Household Members.
  Journal of clinical nutrition and food science 2019 Savoie MB, Paciorek A, Zhang L, Sommovilla N, Venook AP, Van Blarigan EL, Van Loon K
• Periprocedural Management of Patients Undergoing Liver Resection or Embolotherapy for Neuroendocrine Tumor Metastases.
  Pancreas 2019 Kwon DH, Paciorek A, Mulvey CK, Chan H, Fidelman N, Meng L, Nakakura EK, Zhang L, Bergsland EK, Van Loon K
• Exposure to household tobacco smoke and risk of cancer morbidity and mortality: Analysis of data from the Afghanistan Demographic and Health Survey 2015.
  Preventive medicine 2019 Bhatta DN, Hiatt RA, Van Loon K, Glantz SA
• Attitudes and Barriers to Research Among Oncology Trainees in East Africa.
  The oncologist 2019 Rubagumya F, Nyagabona SK, Msami KH, Manirakiza A, Longombe AN, Maniragaba T, Chan H, Paciorek A, Zhang L, Balandya E, Germana LH, Mmbaga EJ, Dharsee N, Van Loon K
• Self-monitoring and reminder text messages to increase physical activity in colorectal cancer survivors (Smart Pace): a pilot randomized controlled trial.
  BMC cancer 2019 Van Blarigan EL, Chan H, Van Loon K, Kenfield SA, Chan JM, Mitchell E, Zhang L, Paciorek A, Joseph G, Laffan A, Atreya CE, Fukuoka Y, Miaskowski C, Meyerhardt JA, Venook AP
• Efficacy of an Intensive, Ultrasound-Guided Fine-Needle Aspiration Biopsy Training Workshop in Tanzania.
  Journal of global oncology 2018 Ng DL, Vuhahula E, Zhang L, Waterhouse EG, White KL, Mushi BP, Nyeriga MS, Philipo GS, Mmbaga EJ, Sheth S, Van Loon K, Lee AY, Balassanian R
• The African Esophageal Cancer Consortium: A Call to Action.
  Journal of global oncology 2018 Van Loon K, Mwachiro MM, Abnet CC, Akoko L, Assefa M, Burgert SL, Chasimpha S, Dzamalala C, Fleischer DE, Gopal S, Iyer PG, Kaimila B, Kayamba V, Kelly P, Leon ME, Mathew CG, Menya D, Middleton D, …
• Does Extended PET Acquisition in PET/MRI Rectal Cancer Staging Improve Results?
  AJR. American journal of roentgenology 2018 Bailey JJ, Jordan EJ, Burke C, Ohliger MA, Wang ZJ, Van Loon K, Varma MG, Hope TA
• The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experimental validation.
  PloS one 2018 Innocenti F, Owzar K, Jiang C, Etheridge AS, Gordân R, Sibley AB, Mulkey F, Niedzwiecki D, Glubb D, Neel N, Talamonti MS, Bentrem DJ, Seiser E, Yeh JJ, Van Loon K, McLeod H, Ratain MJ, Kindler HL, …
• Association Between Intensity of Posttreatment Surveillance Testing and Detection of Recurrence in Patients With Colorectal Cancer.
  JAMA 2018 Snyder RA, Hu CY, Cuddy A, Francescatti AB, Schumacher JR, Van Loon K, You YN, Kozower BD, Greenberg CC, Schrag D, Venook A, McKellar D, Winchester DP, Chang GJ, Alliance for Clinical Trials in …
• Emerging treatment options for BRAF-mutant colorectal cancer.
  Gastrointestinal cancer : targets and therapy 2018 Ursem C, Atreya CE, Van Loon K
• International cancer seminars: a focus on esophageal squamous cell carcinoma.
  Annals of oncology : official journal of the European Society for Medical Oncology 2017 Murphy G, McCormack V, Abedi-Ardekani B, Arnold M, Camargo MC, Dar NA, Dawsey SM, Etemadi A, Fitzgerald RC, Fleischer DE, Freedman ND, Goldstein AM, Gopal S, Hashemian M, Hu N, Hyland PL, Kaimila B, …
• Characteristics of Esophageal Cancer Cases in Tanzania.
  Journal of global oncology 2017 Mmbaga EJ, Deardorff KV, Mushi B, Mgisha W, Merritt M, Hiatt RA, Mwaiselage J, Zhang L, Van Loon K
• Complicated Case Presentation: Management of Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1.
  Pancreas 2017 Mulvey CK, Van Loon K, Bergsland EK, Masharani U, Nakakura EK
• Differential Radiographic Appearance of BRAF V600E-Mutant Metastatic Colorectal Cancer in Patients Matched by Primary Tumor Location.
  Journal of the National Comprehensive Cancer Network : JNCCN 2016 Atreya CE, Greene C, McWhirter RM, Ikram NS, Allen IE, Van Loon K, Venook AP, Yeh BM, Behr SC
• Radioembolization with 90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: final report of a prospective pilot study.
  Journal of gastrointestinal oncology 2016 Fidelman N, Kerlan RK, Hawkins RA, Pampaloni M, Taylor AG, Kohi MP, Kolli KP, Atreya CE, Bergsland EK, Kelley RK, Ko AH, Korn WM, Van Loon K, McWhirter RM, Luan J, Johanson C, Venook AP
• Treatment-related Hypertension as a Pharmacodynamic Biomarker for the Efficacy of Bevacizumab in Advanced Pancreas Cancer: A Pooled Analysis of 4 Prospective Trials of Gemcitabine-based Therapy With Bevacizumab.
  American journal of clinical oncology 2016 Pant S, Martin LK, Geyer S, Wei L, Van Loon K, Sommovilla N, Zalupski M, Iyer R, Fogelman D, Ko AH, Bekaii-Saab T
• SNMMI Comment on the 2016 Society of Surgical Oncology "Choosing Wisely" Recommendation on the Use of PET/CT in Colorectal Cancer.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2016 Zukotynski K, Jadvar H, Hope T, Subramaniam RM, Van Loon K, Varma M, Niederkohr RD, PET Center of Excellence
• Adjuvant Therapy Trials.
  Cancer journal (Sudbury, Mass.) 2016 Ursem C, Van Loon K, Venook A
• A Phase I First-in-Human Study of Nesvacumab (REGN910), a Fully Human Anti-Angiopoietin-2 (Ang2) Monoclonal Antibody, in Patients with Advanced Solid Tumors.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2015 Papadopoulos KP, Kelley RK, Tolcher AW, Razak AR, Van Loon K, Patnaik A, Bedard PL, Alfaro AA, Beeram M, Adriaens L, Brownstein CM, Lowy I, Kostic A, Trail PA, Gao B, DiCioccio AT, Siu LL
• Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas.
  Cancer discovery 2015 Zill OA, Greene C, Sebisanovic D, Siew LM, Leng J, Vu M, Hendifar AE, Wang Z, Atreya CE, Kelley RK, Van Loon K, Ko AH, Tempero MA, Bivona TG, Munster PN, Talasaz A, Collisson EA
• The incidence of oesophageal cancer in Eastern Africa: identification of a new geographic hot spot?
  Cancer epidemiology 2015 Cheng ML, Zhang L, Borok M, Chokunonga E, Dzamamala C, Korir A, Wabinga HR, Hiatt RA, Parkin DM, Van Loon K
• Bone metastases and skeletal-related events from neuroendocrine tumors.
  Endocrine connections 2014 Van Loon K, Zhang L, Keiser J, Carrasco C, Glass K, Ramirez MT, Bobiak S, Nakakura EK, Venook AP, Shah MH, Bergsland EK
• 25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance).
  Journal of the National Cancer Institute 2014 Van Loon K, Owzar K, Jiang C, Kindler HL, Mulcahy MF, Niedzwiecki D, O'Reilly EM, Fuchs C, Innocenti F, Venook AP, Alliance for Clinical Trials in Oncology
• Should combination chemotherapy serve as the backbone in clinical trials of advanced pancreatic cancer? A pooled analysis of phase II trials of gemcitabine-containing doublets plus bevacizumab.
  Pancreas 2014 Van Loon K, Espinoza AM, Fogelman DR, Wolff RA, Javle MM, Iyer RV, Picozzi VJ, Martin LK, Bekaii-Saab T, Tempero MA, Foster NR, Kim GP, Ko AH
• Baseline serum albumin is a predictive biomarker for patients with advanced pancreatic cancer treated with bevacizumab: a pooled analysis of 7 prospective trials of gemcitabine-based therapy with or without bevacizumab.
  Cancer 2014 Pant S, Martin LK, Geyer S, Wei L, Van Loon K, Sommovilla N, Sommovilla N, Zalupski M, Iyer R, Fogelman D, Ko AH, Bekaii-Saab T
• Curable patient with metastatic colorectal cancer: balancing effective therapies and toxicities.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2014 Van Loon K, Venook AP
• Biomarkers in colon cancer: the chasm between expectations and reality.
  Oncology (Williston Park, N.Y.) 2013 Van Loon K, Venook AP
• Gene Profiling in Colon Cancer: How to Integrate Profiling into Practice
  Personalized Medicine in Oncology 2013 Van Loon K, Atreya CE, Kelley RK, Venook AP
• Comparison of dietary and lifestyle habits among stage III and metastatic colorectal cancer patients: findings from CALGB 89803 and CALGB 80405.
  Clinical colorectal cancer 2013 Van Loon K, Wigler D, Niedzwiecki D, Venook AP, Fuchs C, Blanke C, Saltz L, Goldberg RM, Meyerhardt JA
• Counterpoint: Adjuvant therapy in stage II colon cancer: pain not justified by the gain.
  Journal of the National Comprehensive Cancer Network : JNCCN 2012 Van Loon K, Venook AP
• Metastatic colorectal cancer: a curable disease.
  Oncology (Williston Park, N.Y.) 2012 Van Loon K, Venook AP
• 20q- clonality in a case of oral sweet syndrome and myelodysplasia.
  American journal of clinical pathology 2012 Van Loon K, Gill RM, McMahon P, Chigurupati R, Siddiqi I, Fox L, Damon L, McCalmont TH, Jordan R, Wolf J
• Adjuvant treatment of colon cancer: what is next?
  Current opinion in oncology 2011 Van Loon K, Venook AP
• Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects.
  Proceedings of the National Academy of Sciences of the United States of America 2001 Ortiz GM, Wellons M, Brancato J, Vo HT, Zinn RL, Clarkson DE, Van Loon K, Bonhoeffer S, Miralles GD, Montefiori D, Bartlett JA, Nixon DF